Twist Bioscience Corp SEC filings TWST

Twist Bioscience Corp has 1,007 filings in SEC EDGAR's recent list, going back to Oct 4, 2022. Its latest annual report, Form ARS, was filed on Jan 6, 2026 for the period ended Sep 30, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 3, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 19, 2026 (other events). The company's fiscal year ends on September 30.

Twist Bioscience Corp SEC filings
Form Description Filed Period
4 Insider transaction Nov 5, 2026 Nov 3, 2026
4 Insider transaction Nov 5, 2026 Nov 3, 2026
4 Insider transaction Nov 5, 2026 Nov 3, 2026
4 Insider transaction Nov 5, 2026 Nov 3, 2026
4 Insider transaction Nov 5, 2026 Nov 3, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 5, 2026 —
144 Notice of proposed sale Nov 3, 2026 —
144 Notice of proposed sale Nov 3, 2026 —
144 Notice of proposed sale Nov 3, 2026 —
144 Notice of proposed sale Nov 3, 2026 —
144 Notice of proposed sale Nov 3, 2026 —
4 Insider transaction Oct 27, 2026 Oct 23, 2026
144 Notice of proposed sale Oct 23, 2026 —
4 Insider transaction Oct 13, 2026 Oct 9, 2026
144 Notice of proposed sale Oct 9, 2026 —
4 Insider transaction Oct 7, 2026 Oct 5, 2026
144 Notice of proposed sale Oct 5, 2026 —
4 Insider transaction Oct 5, 2026 Oct 2, 2026
4 Insider transaction Oct 5, 2026 Oct 2, 2026
4 Insider transaction Oct 5, 2026 Oct 2, 2026
4 Insider transaction Oct 5, 2026 Oct 1, 2026
4 Insider transaction Oct 5, 2026 Oct 2, 2026
4 Insider transaction Oct 5, 2026 Oct 2, 2026
144 Notice of proposed sale Oct 2, 2026 —
144 Notice of proposed sale Oct 2, 2026 —
144 Notice of proposed sale Oct 2, 2026 —
144 Notice of proposed sale Oct 2, 2026 —
144 Notice of proposed sale Oct 2, 2026 —
144 Notice of proposed sale Oct 2, 2026 —
144 Notice of proposed sale Oct 1, 2026 —
4 Insider transaction Sep 25, 2026 Sep 24, 2026
144 Notice of proposed sale Sep 24, 2026 —
4 Insider transaction Sep 23, 2026 Sep 21, 2026
4 Insider transaction Sep 23, 2026 Sep 21, 2026
4 Insider transaction Sep 23, 2026 Sep 21, 2026
144 Notice of proposed sale Sep 21, 2026 —
144 Notice of proposed sale Sep 21, 2026 —
144 Notice of proposed sale Sep 21, 2026 —
4 Insider transaction Sep 21, 2026 Sep 17, 2026
144 Notice of proposed sale Sep 17, 2026 —
144 Notice of proposed sale Sep 17, 2026 —
4 Insider transaction Sep 10, 2026 Sep 8, 2026
4 Insider transaction Sep 10, 2026 Sep 8, 2026
4 Insider transaction Sep 10, 2026 Sep 8, 2026
4 Insider transaction Sep 10, 2026 Sep 8, 2026
144 Notice of proposed sale Sep 8, 2026 —
144 Notice of proposed sale Sep 8, 2026 —
144 Notice of proposed sale Sep 8, 2026 —
144 Notice of proposed sale Sep 8, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Sep 8, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Sep 8, 2026 —
4 Insider transaction Aug 27, 2026 Aug 25, 2026
144 Notice of proposed sale Aug 25, 2026 —
4 Insider transaction Aug 25, 2026 Aug 21, 2026
4 Insider transaction Aug 25, 2026 Aug 21, 2026
4 Insider transaction Aug 25, 2026 Aug 21, 2026
4 Insider transaction Aug 25, 2026 Aug 21, 2026
4 Insider transaction Aug 25, 2026 Aug 21, 2026
4 Insider transaction Aug 25, 2026 Aug 21, 2026
144 Notice of proposed sale Aug 24, 2026 —
4 Insider transaction Aug 21, 2026 Aug 19, 2026
144 Notice of proposed sale Aug 21, 2026 —
144 Notice of proposed sale Aug 21, 2026 —
144 Notice of proposed sale Aug 21, 2026 —
144 Notice of proposed sale Aug 21, 2026 —
144 Notice of proposed sale Aug 21, 2026 —
144 Notice of proposed sale Aug 21, 2026 —
4 Insider transaction Aug 20, 2026 Aug 18, 2026
8-K Current report
Other events
Aug 19, 2026 Aug 19, 2026
424B7 Filing Aug 19, 2026 —
144 Notice of proposed sale Aug 19, 2026 —
8-K Current report
Regulation FD disclosure
Aug 19, 2026 Aug 18, 2026
144 Notice of proposed sale Aug 18, 2026 —
4 Insider transaction Aug 14, 2026 Aug 12, 2026
4 Insider transaction Aug 14, 2026 Aug 12, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Aug 14, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 13, 2026 —
144 Notice of proposed sale Aug 12, 2026 —
4 Insider transaction Aug 12, 2026 Aug 10, 2026
144 Notice of proposed sale Aug 12, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 11, 2026 —
4 Insider transaction Aug 11, 2026 Aug 7, 2026
144 Notice of proposed sale Aug 10, 2026 —
4 Insider transaction Aug 7, 2026 Aug 5, 2026
144 Notice of proposed sale Aug 7, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Aug 6, 2026 —
8-K Current report
Material agreement, Regulation FD disclosure
Aug 5, 2026 Aug 4, 2026
424B5 Prospectus supplement Aug 5, 2026 —
4 Insider transaction Aug 5, 2026 Aug 3, 2026
4 Insider transaction Aug 5, 2026 Aug 3, 2026
4 Insider transaction Aug 5, 2026 Aug 3, 2026
4 Insider transaction Aug 5, 2026 Aug 3, 2026
4 Insider transaction Aug 5, 2026 Aug 3, 2026
144 Notice of proposed sale Aug 5, 2026 —
424B5 Prospectus supplement Aug 4, 2026 —
10-Q Quarterly report Aug 3, 2026 Jun 30, 2026
144 Notice of proposed sale Aug 3, 2026 —
144 Notice of proposed sale Aug 3, 2026 —
144 Notice of proposed sale Aug 3, 2026 —
144 Notice of proposed sale Aug 3, 2026 —
144 Notice of proposed sale Aug 3, 2026 —
8-K Current report
Results of operations
Aug 3, 2026 Aug 3, 2026
4 Insider transaction Jul 27, 2026 Jul 23, 2026
144 Notice of proposed sale Jul 23, 2026 —
4 Insider transaction Jul 13, 2026 Jul 9, 2026
144 Notice of proposed sale Jul 9, 2026 —
4 Insider transaction Jun 26, 2026 Jun 25, 2026
4 Insider transaction Jun 26, 2026 Jun 24, 2026
144 Notice of proposed sale Jun 25, 2026 —
4 Insider transaction Jun 24, 2026 Jun 22, 2026
4 Insider transaction Jun 24, 2026 Jun 22, 2026
4 Insider transaction Jun 24, 2026 Jun 22, 2026
144 Notice of proposed sale Jun 24, 2026 —
144 Notice of proposed sale Jun 22, 2026 —
144 Notice of proposed sale Jun 22, 2026 —
144 Notice of proposed sale Jun 22, 2026 —
S-3ASR Automatic shelf registration Jun 18, 2026 —
4 Insider transaction Jun 17, 2026 Jun 15, 2026
144 Notice of proposed sale Jun 15, 2026 —
4 Insider transaction Jun 10, 2026 Jun 8, 2026
4 Insider transaction Jun 10, 2026 Jun 8, 2026
4 Insider transaction Jun 10, 2026 Jun 8, 2026
4 Insider transaction Jun 10, 2026 Jun 8, 2026
144 Notice of proposed sale Jun 8, 2026 —
144 Notice of proposed sale Jun 8, 2026 —
144 Notice of proposed sale Jun 8, 2026 —
144 Notice of proposed sale Jun 8, 2026 —
144 Notice of proposed sale Jun 8, 2026 —
4 Insider transaction Jun 2, 2026 May 29, 2026
4 Insider transaction Jun 2, 2026 May 29, 2026
4 Insider transaction Jun 1, 2026 May 28, 2026
4 Insider transaction Jun 1, 2026 May 28, 2026
144 Notice of proposed sale May 29, 2026 —
144 Notice of proposed sale May 29, 2026 —
144 Notice of proposed sale May 28, 2026 —
4 Insider transaction May 28, 2026 May 26, 2026
4 Insider transaction May 28, 2026 May 26, 2026
4 Insider transaction May 28, 2026 May 26, 2026
144 Notice of proposed sale May 28, 2026 —
144 Notice of proposed sale May 27, 2026 —
144 Notice of proposed sale May 26, 2026 —
4 Insider transaction May 26, 2026 May 21, 2026
4 Insider transaction May 26, 2026 May 21, 2026
4 Insider transaction May 26, 2026 May 21, 2026
4 Insider transaction May 26, 2026 May 21, 2026
4 Insider transaction May 26, 2026 May 21, 2026
4 Insider transaction May 26, 2026 May 21, 2026
144 Notice of proposed sale May 26, 2026 —
144 Notice of proposed sale May 26, 2026 —
144 Notice of proposed sale May 21, 2026 —
144 Notice of proposed sale May 21, 2026 —
144 Notice of proposed sale May 21, 2026 —
144 Notice of proposed sale May 21, 2026 —
144 Notice of proposed sale May 21, 2026 —
144 Notice of proposed sale May 21, 2026 —
4 Insider transaction May 14, 2026 May 12, 2026
4 Insider transaction May 12, 2026 May 8, 2026
144 Notice of proposed sale May 12, 2026 —
144 Notice of proposed sale May 8, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 7, 2026 —
4 Insider transaction May 6, 2026 May 4, 2026
4 Insider transaction May 6, 2026 May 4, 2026
4 Insider transaction May 6, 2026 May 4, 2026
4 Insider transaction May 6, 2026 May 4, 2026
4 Insider transaction May 6, 2026 May 4, 2026
10-Q Quarterly report May 4, 2026 Mar 31, 2026
144 Notice of proposed sale May 4, 2026 —
144 Notice of proposed sale May 4, 2026 —
144 Notice of proposed sale May 4, 2026 —
144 Notice of proposed sale May 4, 2026 —
144 Notice of proposed sale May 4, 2026 —
8-K Current report
Results of operations
May 4, 2026 May 4, 2026
SCHEDULE 13G Ownership over 5% (passive) Apr 30, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 30, 2026 —
4 Insider transaction Apr 29, 2026 Apr 27, 2026
4 Insider transaction Apr 27, 2026 Apr 23, 2026
144 Notice of proposed sale Apr 27, 2026 —
4 Insider transaction Apr 23, 2026 Apr 21, 2026
144 Notice of proposed sale Apr 23, 2026 —
144 Notice of proposed sale Apr 22, 2026 —
144 Notice of proposed sale Apr 21, 2026 —
4 Insider transaction Apr 21, 2026 Apr 17, 2026
144 Notice of proposed sale Apr 17, 2026 —
4 Insider transaction Apr 16, 2026 Apr 14, 2026
144 Notice of proposed sale Apr 14, 2026 —
4 Insider transaction Apr 13, 2026 Apr 9, 2026
144 Notice of proposed sale Apr 9, 2026 —
4 Insider transaction Apr 3, 2026 Apr 1, 2026
144 Notice of proposed sale Apr 1, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 27, 2026 —
4 Insider transaction Mar 24, 2026 Mar 20, 2026
4 Insider transaction Mar 24, 2026 Mar 20, 2026
4 Insider transaction Mar 24, 2026 Mar 20, 2026
144 Notice of proposed sale Mar 20, 2026 —
144 Notice of proposed sale Mar 20, 2026 —
144 Notice of proposed sale Mar 20, 2026 —
4 Insider transaction Mar 19, 2026 Mar 17, 2026
144 Notice of proposed sale Mar 17, 2026 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
TWST (Nasdaq)
Fiscal year ends
September 30
Incorporated in
DE
Headquarters
South San Francisco, CA
SEC filer status
Large accelerated filer
SEC CIK
1581280

Other Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.